| |
| |
|
| Insider
Information: |
Daly James M |
| Relationship: |
Director |
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
153,097 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,709,419 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
153,097 |
|
|
| Total
Value |
$1,709,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 37.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Incyte Corp |
INCY |
EVP, Chief Commercial ... |
2015-06-23 |
3,521 |
2014-02-13 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2023-08-14 |
20,503 |
2016-05-04 |
0 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2023-06-01 |
18,002 |
2019-09-09 |
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
109,873 |
2022-01-04 |
0 |
Premium* |
|
|
Madrigal Pharmaceuticals Inc |
MDGL |
Director |
2024-04-02 |
1,198 |
2024-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
• – – |
2015-05-26 |
4 |
AS |
$106.00 |
$1,286,636 |
D/D |
(12,093) |
3,521 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
• – – |
2015-05-26 |
4 |
OE |
$16.62 |
$252,728 |
D/D |
12,093 |
4,502 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
• – – |
2015-06-23 |
4 |
AS |
$107.84 |
$1,265,470 |
D/D |
(11,691) |
3,521 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Commercial Officer |
• – – |
2015-06-23 |
4 |
OE |
$16.62 |
$246,046 |
D/D |
11,691 |
4,502 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-01 |
4 |
AS |
$255.64 |
$5,550,544 |
D/D |
(21,577) |
1,198 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-01 |
4 |
OE |
$100.45 |
$2,174,711 |
D/D |
21,577 |
22,775 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-02 |
4 |
OE |
$105.08 |
$1,146,633 |
D/D |
10,912 |
12,110 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-02 |
4 |
AS |
$243.26 |
$2,668,087 |
D/D |
(10,912) |
1,198 |
0 |
% |
|
58 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
